Japan Approves MSD’s Oral COVID-19 Drug Molnupiravir

December 27, 2021
Health Minister Shigeyuki Goto Reports Molnupiravir Approval on Dec. 24 The Japanese government granted special emergency approval for MSD’s antiviral Lagevrio Capsules (molnupiravir) on December 24, making it the country’s first oral treatment for COVID-19. Health Minister Shigeyuki Goto approved...read more